new glp-1 drug retatrutide Subcutaneous Fat Loss Results: What Clinical Trials Reveal About Effectiveness and Safety Retatrutide Promises Big Weight Loss,

Semaglutide is a widely popular GLP-1 receptor agonist used for the management of type 2 diabetes and obesity

Dual agonists that activate both GLP-1 and GIP receptors tend to cause these side effects slightly more frequently than pure GLP-1 agonists

Weight Loss Injections AND Contraception or HRT Patient Warning: If you are using both a GLP-1 agonist (weight loss injection) and an oral contraception OR oral HRT the effectiveness of your contraception or HRT may be compromised

This study looked aerobic and resistance exercise regimens for people with NAFLD and found similar outcomes in reducing hepatic steatosis but lower total energy consumption in those who completed resistance exercise

Bertoccini L, Baroni MG